Wexford Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$21K 209
2023
Q4
$21K Buy
+20,000
New +$21K ﹤0.01% 192